Imagine a future where medical breakthroughs no longer come at the expense of animals who cannot speak for themselves. A future where scientific innovation allows us to understand human biology without subjecting countless animals to painful and invasive experiments.
That future may be closer than we think.
The Food and Drug Administration (FDA) has recently taken an important step toward modernizing scientific research by issuing a new rule called Nonclinical Testing Terminology. The rule replaces references to “animal tests” and “animal studies” with broader terminology that recognizes a wider range of scientific methods, including human organoids, organ-on-a-chip technology, cell-based testing, computer modeling, and 3D bioprinting.
This is more than a change in terminology. It’s an opportunity to change how we think about the future of science.
Science Has Advanced. It’s Time Our Research Practices Did Too.
We are living in an era of artificial intelligence, advanced computer modeling, human organoids, and 3D bioprinting. Scientists are developing increasingly sophisticated tools that can help us understand human biology and evaluate potential treatments without relying exclusively on animal models.
Yet animals continue to be used in experiments that can involve confinement, invasive procedures, pain, and suffering.
Animals cannot consent to these experiments. They cannot tell us what they are experiencing or ask for a different future. But we can speak up on their behalf.
The FDA Modernization Act of 2022 already recognized that animal testing should not be the only pathway for evaluating drug safety. This new rule helps bring FDA regulations into alignment with that legislation and opens the door to greater recognition of scientifically valid alternatives.
It is an important step toward a future where scientific progress and compassion can move forward together.
Your Voice Can Help Make This Change Happen
The FDA is currently accepting public comments on this rule through December 7, 2026.
That means we have an opportunity to tell federal regulators that we support modernizing research, embracing human-relevant science, and moving away from unnecessary reliance on animal testing.
You don’t need to be a scientist, researcher, or policy expert to participate. You simply need to make your voice heard.
How to Submit Your Comment
Submitting a comment takes just a few minutes:
- Visit Regulations.gov.
- Enter FDA-2026-N-5347-0002 in the search bar.
- Find Nonclinical Testing Terminology and click Comment.
You can also go directly to the FDA’s public comment page here.
Not sure what to write? Here are three simple points you can include:
- I support the nonclinical testing terminology.
- This rule brings FDA regulations in line with legislation Congress has already passed.
- The FDA should finalize this rule as written and without delay.
You can also add a sentence or two about why this issue matters to you personally. Your comment does not need to be lengthy, and you can leave the remaining fields blank without uploading any documents.
A Better Future Starts With Us
Every meaningful change begins with people willing to speak up. We have an opportunity to support scientific innovation that prioritizes human-relevant research while reducing the suffering of animals.
At Honey Paws, we believe animals deserve protection, compassion, and a future free from unnecessary suffering. Whether we are advocating for breeding dogs trapped in puppy mills or speaking out against animal testing, we believe progress should never require turning a blind eye to animal cruelty.
The FDA is asking for public input. Let’s give them an answer they cannot ignore.
Submit your comment before December 7, share this opportunity with others, and encourage your friends and family to participate.
Animals cannot speak for themselves. But together, we can make sure their suffering is not overlooked.
Let’s help build a future where science moves forward without leaving compassion behind.
